Wave Life Sciences Ltd.
NASDAQ:WVE
| Market Cap (Intraday) | 560.21M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $5.02 |
| 50-Day MA | $5.49 |
| 200-Day MA | $5.06 |
Wave Life Sciences Ltd. Stock, NASDAQ:WVE
Marina One East Tower, 7 Straits View, Singapore, Central Singapore 018936
Singapore
Phone: +65.6236.3388
Number of Employees: 268
Description
Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.